XML 20 R3.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Assets    
Cash and cash equivalents $ 56,211 $ 40,784
Investment securities (at fair value)    
Available-for-sale (AFS) debt securities net of allowance for credit losses of $0 (amortized cost of $179,753 and $204,390, respectively) 157,382 181,266
Marketable equity securities 3,326 3,354
Total investment securities 160,708 184,620
Loans and Leases Receivable, Net Amount [Abstract]    
Loans 930,244 921,341
Unearned fees and unamortized loan origination costs - net (1,782) (1,299)
Allowance for credit losses - loans (16,046) (15,658)
Net loans 912,416 904,384
Premises and equipment - net 8,668 9,098
Accrued interest receivable 8,104 7,928
Other real estate owned (“OREO”) 4,582 4,582
Goodwill 4,488 4,488
Deferred tax assets - net 14,419 14,055
Cash surrender value of life insurance - net 20,692 21,954
Investment in limited partnerships 4,275 3,200
Operating lease right-of-use assets 3,069 1,338
Other assets 14,086 14,614
Total assets 1,211,718 1,211,045
Deposits    
Noninterest-bearing 360,152 403,225
Interest-bearing 697,470 601,252
Total deposits 1,057,622 1,004,477
Short-term borrowings 0 62,000
Operating lease liabilities 3,161 1,437
Other liabilities 9,001 9,376
Junior subordinated debentures (at fair value) 11,572 11,213
Total liabilities 1,081,356 1,088,503
Commitments and contingencies (Note 14)
Shareholders’ Equity    
Common stock, no par value; 20,000,000 shares authorized; issued and outstanding: 17,364,894 at December 31, 2024 and 17,167,895 at December 31, 2023 61,267 60,585
Retained earnings 83,447 76,995
Accumulated other comprehensive loss, net of tax (14,352) (15,038)
Total shareholders’ equity 130,362 [1] 122,542 [2]
Total liabilities and shareholders’ equity $ 1,211,718 $ 1,211,045
[1]
(3) Excludes 160,991 unvested restricted shares
[2]
(2) Excludes 21,435 unvested restricted shares